Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome
This study has been completed.
Study NCT00385658   Information provided by Novartis

First Received on October 10, 2006.   Last Updated on November 7, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Dyslipidemia
Additional conditions recognized in this trial
Dyslipidemias
Metabolic Syndrome X
More general conditions related to this trial
Glucose Metabolism Disorders
Hyperinsulinism
Insulin Resistance
Lipid Metabolism Disorders
Metabolic Diseases
Additional drug interventions recognized in this trial
Ezetimibe
Fenofibrate
Fluvastatin
Simvastatin
More general drug interventions related to this trial
Anticholesteremic Agents
Antimetabolites
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Novartis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services